Stago UK Ltd
Moulden Way
COMPANY INFORMATION
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote problem-solving. Customers also benefit from the additional features of our external and internal quality control systems, to monitor system performance and support UKAS accreditation.
Almost one quarter of NHS labs now rely on our robust, highly sensitive and specific assays, whilst automated algorithms aid in the diagnosis of complex disease, helping to rule out potentially costly and unnecessary procedures.
From high throughput instruments to more compact models, Stago is increasingly the provider of first choice for haematology labs. Whether in stand-alone or multi-site network configurations, our highly efficient, instruments have minimal hands-on requirement and align with ease to existing automated systems.
LATEST STORIES
PRODUCTS AND SERVICES
Latest Issues
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
ECP 2026 - 38th European Congress of Pathology
Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026
UK NEQAS Parasitology Symposium
UKHSA, 61 Colindale Avenue, London NW9 5EQ
18 September, 2026
UKHSA Conference 2026
Manchester Central, Manchester, M2 3GX
22-23 September, 2026
Cardiac Marker Dialogues
Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD
24-25 September, 2026
46th European Congress of Cytology
Hilton Antwerp Old Town, Antwerp
4-7 October, 2026